Two studies published in Nature Medicine reveal new therapeutic targets for diffuse intrinsic pontine glioma (DIPG). These aggressive paediatric brainstem tumours are characterized by 5-year survival ...

Diffuse intrinsic pontine gliomas (DIPGs), with a median survival of 9 months, represent the biggest therapeutic challenge in pediatric neuro-oncology. Despite many clinical trials, no major ...

Diffuse intrinsic pontine gliomas (DIPGs), with a median survival of 9 months, represent the biggest therapeutic challenge in pediatric neuro-oncology. Despite many clinical trials, no major ...

DelveInsight's,“ Diffuse Intrinsic Pontine Glioma Pipeline Insight, 2025 ” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Diffuse Intrinsic Pontine Glioma ...

Intravenous thrombolysis (IVT) administered within 4.5 hours was linked to significantly lower risk for neurological deterioration in acute pontine infarction than other antithrombotic therapies, new ...